UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy

BMC pediatrics, 2023-01, Vol.23 (1), p.24-8, Article 24

2023

Volltextzugriff (PDF)

Pharmacometrics: the science of quantitative pharmacology

1, 2007

Volltextzugriff (PDF)

Population pharmacokinetics I: background, concepts, and models

The Annals of pharmacotherapy, 2004-10, Vol.38 (10), p.1702

2004

Volltextzugriff (PDF)

The New Big Is Small: Leveraging Knowledge from Small Trials for Rare Disease Drug Development - Blarcamesine for Rett Syndrome

British journal of clinical pharmacology, 2023-08

2023

Volltextzugriff (PDF)

Population pharmacokinetics II: estimation methods

The Annals of pharmacotherapy, 2004-11, Vol.38 (11), p.1907

2004

Volltextzugriff (PDF)

Pharmacometrics of clobazam in pediatrics: Prediction of effective clobazam doses for Dravet syndrome

Epilepsy research, 2019-11, Vol.157, p.106182-106182, Article 106182

2019

Volltextzugriff (PDF)

Predictors of gentamicin therapy failure in neonates with sepsis

Pharmacology research & perspectives, 2024-08, Vol.12 (4), p.e1250-n/a

2024

Volltextzugriff (PDF)

Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies

The Annals of pharmacotherapy, 2004-12, Vol.38 (12), p.2136

2004

Volltextzugriff (PDF)

A pragmatic approach to the design of population pharmacokinetic studies

The AAPS journal, 2005-10, Vol.7 (2), p.E408-E420

2005

Volltextzugriff (PDF)

Maximizing Knowledge Extraction From Patient‐Reported Outcome Data Using Exposure‐Outcome Item Response Modeling Approach: Understanding Efavirenz‐Induced Central Nervous System Toxicity

Journal of clinical pharmacology, 2020-06, Vol.60 (6), p.711-721

2020

Volltextzugriff (PDF)

A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro

In silico pharmacology, 2023-10, Vol.11 (1), p.31-31, Article 31

2023

Volltextzugriff (PDF)

Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions

Journal of clinical pharmacology, 2016-03, Vol.56 (3), p.365-374

2016

Volltextzugriff (PDF)

Stimulus – Response mechanistic modeling of pharmacodynamic drug-drug interaction: Extension of the operational receptor model of agonism

Informatics in medicine unlocked, 2022, Vol.28, p.100813, Article 100813

2022

Volltextzugriff (PDF)

Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy

Journal of clinical pharmacology, 2015-11, Vol.55 (11), p.1229-1235

2015

Volltextzugriff (PDF)

An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokinetics

Journal of clinical pharmacology, 2016-02, Vol.56 (2), p.213-222

2016

Volltextzugriff (PDF)

Transition modeling of neuropsychiatric impairment in HIV

Computers in biology and medicine, 2016-06, Vol.73, p.141-146

2016

Volltextzugriff (PDF)

Stability and Performance of a Population Pharmacokinetic Model

Journal of clinical pharmacology, 1997-06, Vol.37 (6), p.486-495

Ette, Ene I.

1997

Volltextzugriff (PDF)

Safety and Efficacy of the Multidrug-Resistance Inhibitor Biricodar (VX-710) with Concurrent Doxorubicin in Patients with Anthracycline-resistant Advanced Soft Tissue Sarcoma

Clinical cancer research, 2002-02, Vol.8 (2), p.383-393

2002

Volltextzugriff (PDF)

Model Appropriateness and Population Pharmacokinetic Modeling

Journal of clinical pharmacology, 2003-06, Vol.43 (6), p.610-623

2003

Volltextzugriff (PDF)

The Process of Knowledge Discovery from Large Pharmacokinetic Data Sets

Journal of clinical pharmacology, 2001-01, Vol.41 (1), p.25-34

2001

Volltextzugriff (PDF)

Comparing non-hierarchical models: Application to non-linear mixed effects modeling

Computers in biology and medicine, 1996-11, Vol.26 (6), p.505-512

Ette, Ene I.

1996

Volltextzugriff (PDF)

Conscience, the law, and donation of expired drugs

The Annals of pharmacotherapy, 2004-07, Vol.38 (7-8), p.1310

Ette, Ene I

2004

Volltextzugriff (PDF)

Data supplementation: a pharmacokinetic/pharmacodynamic knowledge creation approach for characterizing an unexplored region of the response surface

Pharmaceutical research, 2005-04, Vol.22 (4), p.523-531

2005

Volltextzugriff (PDF)

Confirming the Suitability of a Gentamicin Dosing Strategy in Neonates Using the Population Pharmacokinetic Approach with Truncated Sampling Duration

Children (Basel), 2024-07, Vol.11 (8), p.898

2024

Volltextzugriff (PDF)

Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization

European journal of drug metabolism and pharmacokinetics, 2002-07, Vol.27 (3), p.213-224

2002

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(37)
Pharmacology & Pharmacy
(36)
Pharmacokinetics
(28)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Pharmacology. Drug Treatments
(25)
Adult
(18)
Female
(15)
Male
(15)
General Pharmacology
(13)
Models, Biological
(12)
Middle Aged
(11)
Pharmacokinetics. Pharmacogenetics. Drug-Receptor Interactions
(11)
Population Pharmacokinetics
(10)
Aged
(9)
Nonmem
(8)
Research Design
(8)
Drug Interactions
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy

Pharmacometrics: the science of quantitative pharmacology

Population pharmacokinetics I: background, concepts, and models

The New Big Is Small: Leveraging Knowledge from Small Trials for Rare Disease Drug Development - Blarcamesine for Rett Syndrome

Population pharmacokinetics II: estimation methods

Pharmacometrics of clobazam in pediatrics: Prediction of effective clobazam doses for Dravet syndrome

Predictors of gentamicin therapy failure in neonates with sepsis

Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies

A pragmatic approach to the design of population pharmacokinetic studies

Maximizing Knowledge Extraction From Patient‐Reported Outcome Data Using Exposure‐Outcome Item Response Modeling Approach: Understanding Efavirenz‐Induced Central Nervous System Toxicity

A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro

Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions

Stimulus – Response mechanistic modeling of pharmacodynamic drug-drug interaction: Extension of the operational receptor model of agonism

Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy

An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokinetics

Transition modeling of neuropsychiatric impairment in HIV

Stability and Performance of a Population Pharmacokinetic Model

Safety and Efficacy of the Multidrug-Resistance Inhibitor Biricodar (VX-710) with Concurrent Doxorubicin in Patients with Anthracycline-resistant Advanced Soft Tissue Sarcoma

Model Appropriateness and Population Pharmacokinetic Modeling

The Process of Knowledge Discovery from Large Pharmacokinetic Data Sets

Comparing non-hierarchical models: Application to non-linear mixed effects modeling

Conscience, the law, and donation of expired drugs

Data supplementation: a pharmacokinetic/pharmacodynamic knowledge creation approach for characterizing an unexplored region of the response surface

Confirming the Suitability of a Gentamicin Dosing Strategy in Neonates Using the Population Pharmacokinetic Approach with Truncated Sampling Duration

Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization

Suchergebnisse filtern